Cargando…

Impact of historic histopathologic sample review on the risk of recurrence in patients with differentiated thyroid cancer

OBJECTIVE: To compare the historic risk of recurrence (RR) and response to therapy to risk stratification estimated with historical pathology reports (HPRs) and contemporary re-review of the pathological slides in patients with differentiated thyroid cancer (DTC). SUBJECTS AND METHODS: Out of 210 DT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pitoia, Fabián, Jerkovich, Fernando, Urciuoli, Carolina, Falcón, Florencia, de Lima, Andrea Páes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118983/ https://www.ncbi.nlm.nih.gov/pubmed/29641733 http://dx.doi.org/10.20945/2359-3997000000020

Ejemplares similares

Selective use of sorafenib in the treatment of thyroid cancer
por: Pitoia, Fabián, et al.
Publicado: (2016)

New approaches for patients with advanced radioiodine-refractory thyroid cancer
por: Pitoia, Fabián, et al.
Publicado: (2022)

Dynamic risk allows us to adequately select patients with differentiated thyroid cancer who do not require radioiodine treatment
por: Abelleira, Erika, et al.
Publicado: (2021)

Dramatic clinical response to dabrafenib plus trametinib in anaplastic thyroid carcinoma and the challenges faced during the COVID-19 pandemic
por: Bueno, Fernanda, et al.
Publicado: (2021)

Rare complications of multikinase inhibitor treatment
por: Pitoia, Fabián, et al.
Publicado: (2018)

Outcomes of patients with bone metastases from differentiated thyroid cancer
por: Califano, Inés, et al.
Publicado: (2018)

Impact of COVID-19 on the thyroid gland: an update
por: Scappaticcio, Lorenzo, et al.
Publicado: (2020)

Dynamic prediction of the risk of recurrence in patients over 60 years of age with differentiated thyroid carcinoma
por: Morosán, Yanina Jimena, et al.
Publicado: (2016)

Active surveillance in low risk papillary thyroid carcinoma
por: Pitoia, Fabian, et al.
Publicado: (2020)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
por: Schmidt, Angelica, et al.
Publicado: (2017)

Complete response to larotrectinib treatment in a patient with papillary thyroid cancer harboring an ETV6‐NTRK3 gene fusion
por: Pitoia, Fabián
Publicado: (2021)

Active surveillance in papillary thyroid carcinoma: not easily accepted but possible in Latin America
por: Smulever, Anabella, et al.
Publicado: (2019)

Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience
por: Smulever, Anabella, et al.
Publicado: (2023)

Thyroid cancer in the Era of COVID-19
por: Smulever, Anabella, et al.
Publicado: (2020)

Radioiodine Thyroid Remnant Ablation after Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal in Patients with High-Risk Differentiated Thyroid Cancer
por: Pitoia, Fabián, et al.
Publicado: (2012)

Timing of multikinase inhibitor initiation in differentiated thyroid cancer
por: Brose, Marcia S, et al.
Publicado: (2017)

Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review
por: Caironi, Verdiana, et al.
Publicado: (2022)

A Three-Domain Scoring System to Customize the Risk of Relapse of Differentiated Thyroid Carcinoma
por: Piccardo, Arnoldo, et al.
Publicado: (2021)

Utility of the Growth Differentiation Factor-15 in the Differential Diagnosis of Follicular-Patterned Lesions of the Thyroid on Cytopathologic and Histopathologic Samples
por: Perumal, Prasanna V, et al.
Publicado: (2023)

Neck Surgery for Non-Well Differentiated Thyroid Malignancies: Variations in Strategy According to Histopathology
por: López, Fernando, et al.
Publicado: (2023)

Differentiated Thyroid Cancer in Navarra (Spain): Historic Cohort Results (1987–2003)
por: Salvador Egea, María Pilar, et al.
Publicado: (2011)

Recurrent Differentiated Thyroid Cancer: The Current Treatment Options
por: Coca-Pelaz, Andrés, et al.
Publicado: (2023)

Hypothyroidism and Thyroid Substitution: Historical Aspects
por: Lindholm, J., et al.
Publicado: (2011)

Recurrent differentiated thyroid cancer: to cut or burn
por: Cirocchi, Roberto, et al.
Publicado: (2011)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
por: Barbosa, Mayara Peres, et al.
Publicado: (2017)

Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study)
por: Gabal, Samia Mohamed, et al.
Publicado: (2018)

Microarchitecture of historic bone samples with tuberculosis
por: Vekszler, György, et al.
Publicado: (2022)

Laboratory Selection Quickly Erases Historical Differentiation
por: Fragata, Inês, et al.
Publicado: (2014)

Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients
por: Walczyk, Agnieszka, et al.
Publicado: (2020)

Histopathologic study of the so called 'palpation thyroiditis'.
por: Hwang, T. S., et al.
Publicado: (1988)

MON-449 Thyroid Microcarcinoma Histopathology Relevance
por: Sandoval, Letícia A M, et al.
Publicado: (2020)

MON-453 Dramatic Clinical Response to Lenvatinib in a Pediatric Patient with Advanced Metastatic Papillary Thyroid Carcinoma
por: Dujovne, Noelia Vanesa, et al.
Publicado: (2020)

Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients
por: Engstrøm, M. J., et al.
Publicado: (2013)

Impact of Multifocality on the Recurrence of Papillary Thyroid Carcinoma
por: Woo, Joohyun, et al.
Publicado: (2021)

Humanitarian crises and child-marriage: Historical recurrent interrelated events
por: Bellizzi, Saverio, et al.
Publicado: (2021)

The impact of minimal extrathyroidal extension in the recurrence of papillary thyroid cancer patients
por: de Almeida, Maria Fernanda Ozorio, et al.
Publicado: (2020)

The dental calculus metabolome in modern and historic samples
por: Velsko, Irina M., et al.
Publicado: (2017)

PFKFB2 Promoter Hypomethylation as Recurrence Predictive Marker in Well-Differentiated Thyroid Carcinomas
por: Camargo Barros-Filho, Mateus, et al.
Publicado: (2019)

Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer
por: Lo, Tom Edward Ngo, et al.
Publicado: (2015)

Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma
por: Na’ara, Shorook, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2it3fqfaun16ov8f6i4lnunjep